Delivery Order SPE2DB24D2216-SPE2DB25FGPFS
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,514.36 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Sumatriptan 6 mg/0.5 mL autoinjectors. This order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp as a single award. The IDC serves as the primary contract vehicle for AmerisourceBergen Drug Corp to...
- This federal contract award is for the delivery of Sumatriptan 6 mg/0.5 ml auto-injectors to the Defense Logistics Agency (DLA). The $2,463.94 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 18, 2024, with a period of performance through October 21, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order for $7,918.73 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4565392037 - Sumatriptan 6 mg/0.5 ml autoinjectors. The contract has a firm fixed price and an ultimate completion date of August 9, 2024. Amerisourcebergen, as a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal agencies to provide a wide range of essential medical supplies, including...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,005.11 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Sumatriptan 6 mg/0.5 ml autoinjectors. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of pharmaceutical products and medical supplies to support military...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,648.91 firm fixed-price contract is for the supply of Sumatriptan 6 mg/0.5 ml autoinjector medication. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 6 mg/0.5 ml sumatriptan auto-injectors. It is a firm fixed price delivery order with a ceiling value of $4,124.04 and an ultimate completion date of July 16, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract has a ceiling value of $1,183.24 and an ultimate completion date of October 21, 2024. It is a firm fixed-price delivery order contract, and no set-aside was used. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,820.06, is for the delivery of Sumatriptan 6 mg/0.5 ml autoinjectors. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 16, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a $48,461.96 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,520,966 units of Sumatriptan 6 mg/0.5 ml auto-injector syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of August 21, 2024. AmerisourceBergen is a key supplier of pharmaceuticals and medical supplies to various federal agencies, including the DLA Troop Support Medical, which...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,422.04 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,565,840,056 units of Sumatriptan 6 mg/0.5 mL autoinjectors. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and Amerisourcebergen, which provides a comprehensive range of medical commodities to support military treatment programs and...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPFSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,249.60 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injector units. This competitive award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price contract with no set-aside designation. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, enabling the contractor to deliver a broad range of medications, vaccines, and medical supplies across multiple therapeutic categories. Through this flexible contract mechanism, AmerisourceBergen fulfills pharmaceutical requirements for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with the DLA planning future Pharmaceutical Prime Vendor Global Program Generation V awards to multiple regional contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 7/18/25 |